Medipharm Labs Corp Stock Target Price
| MEDIF Stock | USD 0.05 0 2.22% |
Medipharm Labs Corp fundamentals help investors to digest information that contributes to Medipharm Labs' financial success or failures. It also enables traders to predict the movement of Medipharm OTC Stock. The fundamental analysis module provides a way to measure Medipharm Labs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medipharm Labs otc stock.
Medipharm |
Medipharm Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medipharm Labs' direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Medipharm Labs could also be used in its relative valuation, which is a method of valuing Medipharm Labs by comparing valuation metrics of similar companies.Medipharm Labs is currently under evaluation in target price category among its peers.
Medipharm Fundamentals
| Return On Equity | -0.57 | |||
| Return On Asset | -0.24 | |||
| Profit Margin | (2.07) % | |||
| Operating Margin | (1.61) % | |||
| Current Valuation | 3.05 M | |||
| Shares Outstanding | 280.51 M | |||
| Shares Owned By Insiders | 3.92 % | |||
| Shares Owned By Institutions | 7.05 % | |||
| Price To Book | 0.36 X | |||
| Price To Sales | 0.69 X | |||
| Revenue | 21.71 M | |||
| Gross Profit | (13.42 M) | |||
| EBITDA | (38.55 M) | |||
| Net Income | (54.8 M) | |||
| Cash And Equivalents | 21.99 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 1.44 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 5.23 X | |||
| Book Value Per Share | 0.22 X | |||
| Cash Flow From Operations | (13.21 M) | |||
| Earnings Per Share | (0.14) X | |||
| Number Of Employees | 190 | |||
| Beta | 1.15 | |||
| Market Capitalization | 16.26 M | |||
| Total Asset | 92.36 M | |||
| Z Score | 6.6 | |||
| Net Asset | 92.36 M |
About Medipharm Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medipharm Labs Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medipharm Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medipharm Labs Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Medipharm OTC Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.